Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.
May 14, 2015
Ten years ago, in May 2005, world-renowned biostatistician Marvin Zelen was asked to deliver a keynote address before...
Read article
May 13, 2014
De-Risking Drug Development using Adaptive Design
The VALOR trial recently applied a promising zone design to a Phase 3 evaluation of Vosaroxin, a candidate for the...
Read article